Evaluation of Liquid vs. Tablet Buprenorphine - 6

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to evaluate the steady-state pharmacokinetics and bioavailability of buprenorphine sublingual tablets vs. sublingual solution.

Key facts

Study ID

NCT00000341

Run by

National Institute on Drug Abuse (NIDA)

People needed

1

Starts

1996-08-01

Expected to finish

2000-08-01

Last updated by the study team

2017-01-12

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• M/F ages 21-50. Meet DSM-IV criteria for opioid dependence. Agree to conditions of the study and sign informed consent.

You may not qualify if…

• Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.

Where it is running

• Friends Research Institute — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.